Treatment of Major Depressive Disorder Using Botulinum Toxin A
2014 · The Journal of Clinical Psychiatry · 132 citations
https://doi.org/10.4088/jcp.13m08845
M
M. Axel Wollmer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
87
Papers
4.1K
Citations
29
h-index
49
i10-index
M. Axel Wollmer is an academic researcher from Asklepios Kliniken Hamburg. The author has contributed to research in topics: Botulinum Toxin and Related Neurological Disorders & Neurological disorders and treatments & Alzheimer's disease research and treatments. The author has an h-index of 29, co-authored 74 publications.
Papers by this author
worksBotulinum Toxin as a Treatment for Depression in a Real-world Setting
2018 · Journal of Psychiatric Practice · 35 citations
https://doi.org/10.1097/pra.0000000000000277
Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety
2021 · Scientific Reports · 20 citations
https://doi.org/10.1038/s41598-021-03713-x
Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder
2022 · Scientific Reports · 15 citations
https://doi.org/10.1038/s41598-022-17509-0
Gedächtnisambulanzen in Deutschland – strukturell-organisatorische Voraussetzungen und Aufgabenfelder
2020 · Der Nervenarzt · 10 citations
https://doi.org/10.1007/s00115-020-01007-7
Shrink that frown! Botulinum toxin therapy is lifting the face of psychiatry
2018 · Italian Journal of Dermatology and Venereology · 5 citations
https://doi.org/10.23736/s0392-0488.18.05987-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat